Serial Number
99833149
Owner
Spruce Biosciences, Inc.Attorney
John Paul OleksiukFiling Date
May 19, 2026
SPRUCEASSIST Trademark
Serial Number: 99833149
Trademark Classes
Owner Contact Info
611 Gateway Boulevard, Suite 740
South San Francisco, CA 94080
Entity Type: 03
Legal Representation
Correspondence Address
John Paul Oleksiuk Cooley LLP
1299 Pennsylvania Avenue, NW, Suite 700
Washington, DC 20004
United States
Trademark Details
Filing Date
May 19, 2026
Registration Date
Not Registered
Published for Opposition
September 8, 2026
Goods & Services
Providing medical information in the field of neurodegenerative disorders and treatment thereof; Providing a website featuring medical information about pharmaceuticals to improve understanding by patients and caregivers for the purpose of providing support to pharmaceutical patients and to improve understanding by patients and caregivers about pharmaceuticals; Providing resources to patients in the nature of product information for medical purposes, namely, providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals and providing information to patients in the field of administering medications
Providing a website featuring technology that enables users to access educational and informational materials about medical conditions and diseases, pharmaceutical product and use information, resources for patient support and advocacy programs and treatment affordability programs, and accessing pharmaceuticals; Providing an interactive website featuring technology that enables users to access educational and informational materials about medical conditions and diseases, pharmaceutical product and use information, resources for patient support and advocacy programs and treatment affordability programs, and accessing pharmaceuticals; Providing online non-downloadable software for users to access educational and informational materials about medical conditions and diseases, pharmaceutical product and use information, resources for patient support and advocacy programs and treatment affordability programs, and accessing pharmaceuticals; Providing medical and scientific research information in the field of neurodegenerative disorders and treatment thereof